Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: post-hoc analysis from double-blind combined BIPARK-I and II data.

被引：0
作者：
Costa, R.
Lees, A.
Ferreira, J.
Rascol, O.
Stocchi, F.
Gama, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
MOTOR FLUCTUATIONS; OPICAPONE; LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
83
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [41] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: The BIPARK-I double-blind experience
    Kulisevsky, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S106 - S106
  • [42] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: NMSS analysis from the BIPARK-I double-blind experience
    Antonini, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S135 - S136
  • [43] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: UPDRS-II and III analysis from the BIPARK-I double-blind experience
    Ebersbach, G.
    Ferreira, J.
    Stocchi, F.
    Costa, R.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S148 - S148
  • [44] Impact of opicapone treatment in UPDRS-II and III scores in Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience
    Ebersbach, G.
    Ferreira, J.
    Stocchi, F.
    Costa, R.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 462 - 462
  • [45] Efficacy responders to opicapone among Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 155 - 155
  • [46] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Responder analyses from the BIPARK-I double-blind experience
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S103 - S104
  • [47] Effect of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Parkinson's disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
    Rocha, F.
    Tolosa, E.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [48] Effect of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Parkinson's Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
    Rocha, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Rascol, O.
    Poewe, W.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S78 - S79
  • [49] Impact of opicapone treatment in non-motor symptoms scale in Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience
    Antonini, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Gama, H.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 449 - 449
  • [50] Baseline OFF-time influence in opicapone's efficacy outcomes in Parkinson's disease patients with motor fluctuations: The BIPARK-I double-blind data
    Korlipara, P.
    Ferreira, J.
    Gama, H.
    Santos, A.
    Ikedo, F.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 649 - 649
12345